Publication:
Recombinant Factor VIII Half Life Using a Bayesian Model in Patients with Severe Haemophilia A on Prophylaxis in Turkey

dc.contributor.authorAlbayrak, C.
dc.contributor.authorAlbayrak, D.
dc.date.accessioned2020-06-21T12:27:55Z
dc.date.available2020-06-21T12:27:55Z
dc.date.issued2019
dc.departmentOMÜen_US
dc.department-temp[Albayrak, C.] Ondokuz Mayis Univ, Med Fac, Pediat Hematol Dept, Samsun, Turkey -- [Albayrak, D.] Samsun Medicalpk Hosp, Pediat Hematol Dept, Samsun, Turkey --en_US
dc.description.abstracten_US
dc.identifier.endpage64en_US
dc.identifier.issn1351-8216
dc.identifier.issn1365-2516
dc.identifier.startpage64en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/10996
dc.identifier.volume25en_US
dc.identifier.wosWOS:000457408400103
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.journalHaemophiliaen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleRecombinant Factor VIII Half Life Using a Bayesian Model in Patients with Severe Haemophilia A on Prophylaxis in Turkeyen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files